Mitotic cdc2 Kinase and Alzheimer Neurodegeneration
Principal Investigator
Inez Vincent, PhD
Seattle Institute for Biomedical and Clinical Research
Seattle, WA, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$80,000
Active Dates
April 01, 1999 - March 31, 2001
Grant ID
A1999039
Summary
Dr. Vincent is exploring the hypothesis that some of the processes that cause cancer in dividing cells can also occur in non-dividing neurons. Because neurons cannot divide, these processes may lead to cell degeneration and cell death. She has already found that some of the proteins that are key to cell division and cell growth are present in the dying neurons of Alzheimer’s disease. These cell proteins are sometimes detectable in neurons even before the appearance of the lesions characteristic of AD. In this study, Dr. Vincent is testing whether introducing these cell cycle proteins into normal neurons will produce AD lesions. Once this question is answered, she will then attempt to determine if the known genetic mutations associated with AD affect the expression of the cell cycle proteins, and if so, how they do so.
Related Grants
Alzheimer's Disease Research
Progranulin as a Potential Therapeutic Target for Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Andrew Nguyen, PhD
Current Organization
Saint Louis University
Progranulin as a Potential Therapeutic Target for Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Andrew Nguyen, PhD
Current Organization
Saint Louis University
Alzheimer's Disease Research
Does Alzheimer’s Disease Accelerate Brain Aging?
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
MaríA Llorens-Martín, PhD
Current Organization
Spanish National Research Council
Does Alzheimer’s Disease Accelerate Brain Aging?
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
MaríA Llorens-Martín, PhD
Current Organization
Spanish National Research Council
Alzheimer's Disease Research
Mechanisms of Inhibitory Neuron Vulnerability to Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Emiliano Zamponi, PhD
Current Organization
Columbia University
Mechanisms of Inhibitory Neuron Vulnerability to Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Emiliano Zamponi, PhD
Current Organization
Columbia University